United Kingdom Angioplasty Balloons Market Insight
Published: 04 June 2026 | Report Format: Electronic (PDF)
The United Kingdom Angioplasty Balloons Market is projected to grow at a CAGR of around 7.0%, driven by rising cardiovascular disease prevalence, minimally invasive procedures, aging population, and advanced balloon technologies.
United Kingdom Angioplasty Balloons Market Forecasts to 2035
- The United Kingdom Angioplasty Balloons Market Size was estimated at USD 220.0 Million in 2025
- The Market is expected to grow at a CAGR of around 7.0% from 2025 to 2035
- The United Kingdom Angioplasty Balloons Market Size is expected to reach around USD 433.0 Million by 2035
Notable Insights for the United Kingdom Angioplasty Balloons Market
- Segmentation by application, including coronary artery interventions, peripheral artery disease, and neurovascular procedures, with coronary interventions accounting for the largest share nearly 56% in 2025, driven by high prevalence of cardiovascular diseases, aging population, and increasing PCI procedures across UK hospitals.
- Segmentation by end-use, including hospitals, cardiac catheterization laboratories, and specialty cardiovascular centers, where hospitals and cath labs dominate the market with over 65% share in 2025, driven by high patient inflow, advanced infrastructure, and increasing adoption of minimally invasive cardiovascular procedures.
- The United Kingdom Angioplasty Balloons Market is led by key players such as Medtronic, Boston Scientific, Abbott Laboratories, B. Braun, and Terumo Corporation, collectively accounting for nearly 56% share in 2025, driven by strong product portfolios, advanced balloon catheter technologies, and widespread hospital adoption.
Download the eBook (ToC)
- Rising demand for minimally invasive cardiovascular procedures, increasing prevalence of coronary artery disease, growing geriatric population, and continuous innovation in drug-coated and non-compliant balloon systems are key growth drivers, collectively contributing to nearly 50% of overall market expansion in 2025 across the UK healthcare system.
Research Methodologies Used to Analyze United Kingdom Angioplasty Balloons Market
The United Kingdom Angioplasty Balloons Market is analyzed using a combination of primary and secondary research methodologies to ensure accurate insights and reliable forecasts. Primary research includes interviews with interventional cardiologists, hospital procurement teams, cath lab technicians, medical device manufacturers, distributors, and regulatory authorities to assess procedural demand, product performance, clinical outcomes, technology adoption, and pricing trends of angioplasty balloon catheters in cardiovascular treatments. Secondary research involves reviewing company annual reports, cardiovascular device industry publications, NHS and government healthcare databases, clinical guidelines, medical journals, hospital procurement data, and market intelligence sources to understand market trends, competitive landscape, innovation in balloon catheter technologies, adoption of drug-coated and non-compliant balloons, and the overall growth dynamics of minimally invasive cardiovascular procedures in the UK.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Angioplasty Balloons Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Angioplasty Balloons Market
- Medtronic
- Abbott Laboratories
- Boston Scientific
- B. Braun
- Terumo Corporation
- Becton Dickinson
- BIOTRONIK
- Teleflex Incorporated
- Cook Medical
- Cordis
Recent Developments:
- In May 2025, Boston Scientific expanded its UK cardiovascular portfolio by advancing next-generation drug-coated and high-pressure angioplasty balloon systems, improving restenosis control, lesion crossability, and procedural outcomes in complex coronary interventions across NHS hospitals.
- In April 2025, Abbott Laboratories strengthened its interventional cardiology offerings in the UK by enhancing advanced coronary balloon catheter technologies, focusing on improved deliverability, vessel conformity, and safety performance in minimally invasive angioplasty procedures.
Market Segmentation:
United Kingdom Angioplasty Balloons Market, By Product Type
- Semi-compliant balloons
- Non-compliant balloons
- Compliant balloons
- Drug-coated balloons
- Cutting/scoring balloons
United Kingdom Angioplasty Balloons Market, By Application
- Coronary artery disease treatment
- Peripheral artery disease treatment
- Neurovascular interventions
- Chronic total occlusion (CTO) procedures
- In-stent restenosis treatment
- Other interventional cardiology procedures
United Kingdom Angioplasty Balloons Market, By End User
- Hospitals
- Cardiac catheterization laboratories (Cath labs)
- Specialty cardiac centers
- Ambulatory surgical centers
- Academic & research hospitals
Expert Views:
The United Kingdom Angioplasty Balloons Market is experiencing steady growth driven by rising cardiovascular disease burden, increasing adoption of minimally invasive interventions, and advancements in balloon catheter technologies. Hospitals and cath labs remain key demand centers, supported by strong OEM competition and innovation in drug-coated and non-compliant balloons, positioning the market for sustained expansion and improved procedural outcomes through 2035.
Author: Govind and Krishna By Spherical Insights and Consulting